STROBOSENSE offers a revolutionary single-shot Optical Coherence Elastographic system for real-time, in-vivo imaging. Utilizing off-axis interferometry and low coherence light sources, it enables new contrast modalities like shear wave elastography and Doppler imaging.
STROBOSENSE introduces a groundbreaking single-shot Optical Coherence Elastographic (OCE) system designed for real-time observation and imaging of living tissues. Unlike traditional Full-Field Optical Coherence Tomography (FF-OCT) systems that require multiple acquisitions, STROBOSENSE leverages single-shot amplitude and phase measurements. This innovation allows for advanced contrast modalities including shear wave elastography, photo-thermal contrast, and Doppler imaging, broadening the scope of medical diagnostics.
Key Features:
Currently at Technology Readiness Level 5, STROBOSENSE is in the prototype phase. A co-engineering program with industrial partners is being pursued to identify specific applications and tailor development efforts. This will ensure technological advancements align with market needs, leading to a proof of concept and eventual market launch by 2026.
TTO CONECTUS is based in Strasbourg, specialized in enhancing and maturing disruptive technologies in MEDTECH-CHEMISTRY-BIOTECH. We reach a proof of concept with industrial partners for licencing.